NEEDHAM, MASSACHUSETTS, UNITED STATES, February 19, 2025 /EINPresswire.com/
OpenClinica today announced its CRO partnership program designed exclusively to help contract research organizations (CROs) compete and win new business. The CRO partnership program features:
- Proven, innovative best-in-class eClinical solutions,
- EHR-to-EDC integration,
- Expert product training,
- Sales enablement,
- Joint marketing,
- Financial incentives, and
- Compliance support and resources.
OpenClinica intimately understands the needs of contract research organizations and built a CRO partnership program to help them win business,” said Ben Baumann, OpenClinica’s Co-Founder and COO. “We help CROs deliver value for clinical trial sponsors by streamlining operations, accelerating study builds and engineering a seamless experience.”
The CRO market has been steadily growing. As of 2024, there were 4,321 CRO businesses in the United States. Between 2019 and 2024, the number of CROs grew three percent per year on average. Estimates suggest that CROs conduct nearly three out of every four clinical trials.
Improving margins is critical for CROs seeking differentiation in a very competitive market, emphasized Baumann. “Partnering with OpenClinica enables CROS to optimize workflows, reduce trial costs and increase operational efficiency.”
To learn more about OpenClinica’s CRO partnership program, visit here!
About OpenClinica
OpenClinica accelerates clinical trials by automating data acquisition through its software-as-a-service platform. Offering a secure bridge between healthcare and research, OpenClinica is trusted by the world’s foremost life science companies, academic institutions, and government entities and has been used in more than 10,000 studies involving over five million patients. OpenClinica is proud to support hundreds of small, midsize and large research organizations spanning biotech, pharma, medical device manufacturing and contract research organizations. For more information, visit us at www.openclinica.com.